Evidence map›Paper›PMID 39439527›Full record

ArticleToxicology research2024

Effects of Immunotoxicity biomarkers, essential elements and vitamin D levels on the severity levels of COVID-19 disease in Turkey.

Jülide Secerlı, Serdar Çetinkaya, İlknur Sıla Leblebici, Latif Alperen Özdemir, Çiğdem Yücel, Eda Karaismailoğlu, Umut Kara, Aydan Özcan, Nesrin Öcal, Yakup Arslan and 3 more

Abstract read
In one paragraph

Article in Toxicology research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jülide SecerlıDepartment of Pharmaceutical Toxicology, University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, 06018 Ankara, Türkiye.ORCID https://orcid.org/0000-0002-4875-2266
Serdar ÇetinkayaDepartment of Pharmaceutical Toxicology, University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, 06018 Ankara, Türkiye.ORCID https://orcid.org/0000-0001-9469-5066
İlknur Sıla LeblebiciDepartment of Pharmaceutical Toxicology, University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, 06018 Ankara, Türkiye.ORCID https://orcid.org/0000-0003-3752-1777
Latif Alperen ÖzdemirDepartment of Chest Diseases, University of Health Sciences Turkey, Gülhane Research and Training Hospital, 06018 Ankara, Türkiye.ORCID https://orcid.org/0009-0002-6781-5960
Çiğdem YücelDepartment of Pharmaceutical Biochemistry, University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, 06018 Ankara, Türkiye.ORCID https://orcid.org/0000-0003-2647-440X
Eda KaraismailoğluDepartment of Biostatistics, University of Health Sciences Turkey, Gülhane Faculty of Medicine, 06018 Ankara, Türkiye.ORCID https://orcid.org/0000-0003-3085-7809
Umut KaraGeneral Intensive Care Unit, Special Acıbadem Ataşehir Hospital, 34758 İstanbul, Türkiye.ORCID https://orcid.org/0000-0001-5233-8255
Aydan ÖzcanDepartment of Sports Medicine, University of Health Sciences Turkey, Gülhane Faculty of Medicine, 06018 Ankara, Türkiye.ORCID https://orcid.org/0000-0003-1868-0617
Nesrin ÖcalDepartment of Chest Diseases, University of Health Sciences Turkey, Gülhane Research and Training Hospital, 06018 Ankara, Türkiye.ORCID https://orcid.org/0000-0002-3789-7769
Yakup ArslanDepartment of Chest Diseases, University of Health Sciences Turkey, Gülhane Research and Training Hospital, 06018 Ankara, Türkiye.ORCID https://orcid.org/0000-0002-7614-1198
Serkan ŞenkalGeneral Intensive Care Unit, Special Acıbadem Ataşehir Hospital, 34758 İstanbul, Türkiye.ORCID https://orcid.org/0000-0002-4571-3923
Onur ErdemDepartment of Pharmaceutical Toxicology, University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, 06018 Ankara, Türkiye.ORCID https://orcid.org/0000-0002-5849-3552
Merve Güdül BacanlıDepartment of Pharmaceutical Toxicology, University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, 06018 Ankara, Türkiye.ORCID https://orcid.org/0000-0001-8757-0572

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many mechanisms are thought to play a role in the pathogenesis of the COVID-19 pandemic, which started in 2019 and affected the whole world. It has been claimed that a deficiency in the immune system can significantly affect the severity of COVID-19 disease. It is important that the levels of essential elements and vitamin D are at certain levels for the healthy functioning of the immune system. Therefore, in this study, it was aimed to evaluate immunotoxicity biomarkers (tumor necrosis factor-alpha (TNF-α), interleukin (IL)-10, interferon (IFN)-γ, monocyte chemotactic protein-1 (MCP-1)), vitamin D, and essential element levels in COVID-19 patients in Turkey. According to the results of the study, it was found that the magnesium (Mg), zinc (Zn), and selenium (Se) levels decreased as the severity of the disease worsened, while the iron (Fe), and copper (Cu) levels were similar to the mild group and the control group, and the levels decreased as the disease worsened. It has also been found that vitamin D levels decrease as the severity of the disease worsens. Compared to the control group, TNF-α, MCP-1, and IFN-γ levels were found to decrease as the severity of the disease worsened. Also, it was observed that there was a significant relationship between essential metal levels and disease progression in most of the patient groups.

Indexed as

COVID-19Essential elementImmunotoxicitySARS-CoV-2Vitamin D

Identifiers

PMID39439527
PMCPMC11491277

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.